Denileukin diftitox-induced systemic capillary leak syndrome with acute kidney injury

CEN Case Rep. 2023 Feb;12(1):63-67. doi: 10.1007/s13730-022-00720-3. Epub 2022 Jul 23.

Abstract

Systemic capillary leak syndrome is a rare and life-threatening disorder, characterized by recurrent episodes of unexplained hypotension, hemoconcentration, and hypoalbuminemia. This condition is caused by leakage of plasma and proteins into the extravascular space and can be classified as either idiopathic or secondary. Secondary systemic capillary leak syndrome can result from cancer, infections, medications, or surgery. Systemic capillary leak syndrome frequently develops as a side effect of denileukin diftitox treatment of refractory cutaneous T-cell lymphoma. However, the pathophysiology of this disease is not well understood. Herein, we report a case of denileukin diftitox-induced systemic capillary leak syndrome.

Keywords: 99mTc-HSA scintigraphy; Acute kidney injury; Cutaneous T-cell lymphoma; Denileukin diftitox; Interleukin-2 receptors; Systemic capillary leak syndrome.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / complications
  • Capillary Leak Syndrome* / chemically induced
  • Capillary Leak Syndrome* / diagnosis
  • Capillary Leak Syndrome* / drug therapy
  • Humans
  • Interleukin-2 / adverse effects
  • Skin Neoplasms* / complications
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology

Substances

  • denileukin diftitox
  • Interleukin-2